Intelligent Bio Solutions Inc. (INBS) Operating margin 2020–2026
Intelligent Bio Solutions Inc. (INBS) operating margin by fiscal year — reported operating income divided by reported revenue.
-299.1%FY2026 · since FY2020: -1513.7% → -299.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -299.1% | +50.7 pp |
| FY2025 | -349.8% | -19.4 pp |
| FY2024 | -330.5% | +671.7 pp |
| FY2023 | -1002.1% | +905.0 pp |
| FY2022 | -1907.1% | -1625.7 pp |
| FY2021 | -281.4% | +1232.3 pp |
| FY2020 | -1513.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INBS financial trends
INBS RevenueINBS Net incomeINBS Net marginINBS Gross profitINBS Gross marginINBS Operating incomeINBS Operating cash flowINBS Free cash flowINBS Capital expendituresINBS Return on equityINBS Stock buybacksINBS Dividends paidINBS Total assetsINBS Total liabilitiesINBS Shareholders’ equityINBS overview →